Friday, September 29, 2017

AppSwarm, Inc. (SWRM) Aims to Increase Share of the Global Apps and Games Market


  • AppSwarm helps build, market and sell applications through mergers and acquisitions, joint ventures, partnerships and various other agreements
  • The company is aiming for $6-7 million in revenue by FY 2018, tapping into the nearly $100 billion global games market
  • The app market hit $1.3 trillion in 2016, and AppSwarm’s agreements with major app stores can help developers get to market sooner

In 2016, the global games market generated nearly $100 billion in revenue. AppSwarm, Inc. (OTC: SWRM) has built a business model that enables it to work with application developers and entrepreneurs who are great at creating ideas, but need a helping hand with marketing their products. AppSwarm has the financial resources to assist small application development firms and young entrepreneurs. It employs many strategies, depending on the individual business relationship. The firm has grown through acquisitions and by entering joint ventures and partnerships, royalty agreements and stock purchase agreements.

The company recently announced that it is striving for $6-7 million in revenue by FY2018 (http://nnw.fm/Xlb8N). A strong presence in the business, e-commerce, and general games market can help it get there. AppSwarm has structured its model to cater to historically profitable software developers that show growth potential. Merging with such companies, even small developers, gives them the needed financial resources, marketing tools and business management assistance to further their products.

A unique business model is centered on what the company calls the “Swarm.” This process focuses on engagement and retention, the performance of target applications and developers, and a monetization model. Four key revenue streams are implemented. The company is strongly involved in completing the concept and development phase and conducting all necessary functions to get the product on the market. It provides direct sales services as well. Together, these service offerings allow for the incubation of apps from ideation to sale to the end user.

AppSwarm is also active in social game development, both internally and through redeveloping existing apps. Other revenue streams include casino and movie-themed role-playing applications, but the company has also profited by partnering with many different entities, offering financial, operations and marketing resources and expertise. Providing cost-efficient processes to its partners and clients has made SWRM a viable choice for developers looking to give their products a boost.

The app market reached $1.3 trillion in 2016, according to App Annie. Expected to grow substantially over the next few years, the app market is extremely volatile and includes almost every product and service sector. Purchases such as Urban Bamboo Designs, a business serving environmentally conscious consumers looking for quality, stylish products, and VR World, a maker of virtual reality and augmented reality applications, have enabled SWRM to tap into lucrative revenue streams. It has even entered the business applications segment, thanks to a PDF document scanner that works with iPhones and iPads.

An ability to expedite development, financing, creation, and marketing and sales is allowing the company to tap into the large and growing global app market. Agreements with major app stores are in place. AppSwarm can therefore fast track applications so developers can launch their software, satisfy demand in key niches and turn a profit without extended wait periods. The agreements SWRM is capable of managing are enabling it to rapidly increase its presence in the global market.

For more information, visit the company’s website at www.App-Swarm.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Bowser Small Cap Stocks Grew 2.6% for Week Ended September 22, Outperforming Major Indices


  • Leading the way was InfuSystem Holdings (NYSE MKT: INFU), which grew 23%
  • Russell 2000 Index increased 1.3%, faster than other major indices
  • Second week in a row Bowser Stocks surged higher

Bowser small cap stocks grew 2.6% for the week ended September 22, outperforming major indices, according to The Bowser Report Weekly. InfuSystem Holdings (NYSE MKT: INFU) led the way, growing 23% for the week. Ironically, INFU was the single biggest loser the prior week, with The Bowser Report Weekly attributing that selloff to an increase in volatility. The company provides infusion pumps and related services to medical facilities.

It was the second week in a row that Bowser Stocks showed growth. The Russell 2000 index grew at a 1.3% rate, outperforming the major indices. The Dow Jones Industrial Average (DJIA) grew just 0.4%, and the S&P 500 was up only 0.1%. The report said that smaller stocks are exhibiting relative strength for the one-month period. It expects, though, a loss of growth momentum at a historical supply zone.

The second biggest gainer was Nova Lifestyle (NASDAQ: NVFY), which showed 18% growth. That stock is now up 54% from its 52-week low. The company earlier announced in a press release that it was receiving an award and also expecting growth in the fourth quarter, driven by new product launches and an increase in consumer demand. It is a California-based consumer furniture manufacturer.

For the week, 32 Bowser stocks showed growth and only 11 were in the red. The report added that gold experienced a sharp pullback for the week due to the strength of the U.S. dollar. The report attributed that to a Federal Reserve decision to leave interest rates unchanged.

For more information, refer to The Bowser Report Weekly

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Tech Discussed at “Cannabis in the Capital Markets” Event


  • Clinical studies of TurboCBD™ a topic of discussion at Canadian Securities Exchange-sponsored “Cannabis in the Capital Markets” event
  • Patents cover variety of lipophilic bio-actives, including cannabinoids, nicotine and vitamins
  • Growing portfolio of intellectual property includes 19 patents filed across 44 countries

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), through its proprietary technology for delivering bioactive compounds in lipid formulations, offers licensed partners the ability to include cannabidiol (CBD) in a variety of ingestible products appropriate for medical patients and recreational users alike. In a new report, Grand View Research, Inc., states that the global market for medical cannabis alone is expected to reach a stunning $55.8 billion by 2025 (http://nnw.fm/Ou2Xa). An increasing interest in the therapeutic value of cannabinoids, especially those delivered in products that can be ingested and not smoked, is one of the main forces driving the market forward, per the report.

Lexaria’s pioneering TurboCBD ™ product presents a revolutionary way to enhance absorption of the benefits CBD provides without having to endure the often unpleasant flavors associated with cannabis compounds. Lexaria’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, with patents pending for THC (tetrahydrocannabinol) and other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and additional molecules.

Dr. Philip Ainsle of the University of British Columbia (UBC) is the principal investigator of Lexaria’s first clinical study of the high-absorption properties of TurboCBD™. The study will evaluate the effects of TurboCBD™ on the cognitive function and cardiovascular health of human volunteers. Dr. Ainsle, co-director of the Centre for Heart, Lung and Vascular Health at the UBC Okanagan Campus in Kelowna, Canada, presented a project update at the Canadian Securities Exchange-sponsored “Cannabis in the Capital Markets” event on September 27 (http://nnw.fm/9MopZ). Lexaria representatives are also scheduled to speak in October at the Southwest Cannabis Conference and Expo in Phoenix, Arizona.

As a business-to-business enterprise, Lexaria’s reach extends to companies located in Canada, several large market states in the U.S., and internationally. An 18-month co-funded research project is underway with Canada’s National Research Council to investigate opportunities associated with bioavailability enhancement of lipophilic active agents – including those within cannabinoids, vitamins, NSAIDs and nicotine. Results from this study could provide Lexaria with a chemical or physical “fingerprint” that could help to identify Lexaria’s technology at work in consumer products.

Lexaria’s technology is capable of helping companies lower costs while providing the best consumer benefit possible. Several third-party partners have signed deals, letters of intent or memorandums of understanding to utilize Lexaria’s proprietary technology for both THC and CBD products where allowed by law. Lexaria and its partners are targeting markets in Canada, the U.S., Japan, South Korea, Mexico and more. Lexaria’s royalty revenue model includes a range of between five and 10 percent of gross sales.

As a bioscience technology disruptor for edible cannabinoids, Lexaria has several branded CBD products available, including protein energy bars, CBD tablets that contain zero sugar, premium teas and TurboCBD ™ in a high absorption, full spectrum hemp oil capsule. Led by CEO Chris Bunka, Lexaria’s management team includes professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skill sets.

For more information, visit the company’s website at www.LexariaEnergy.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Luxury Utah Home for Sale Now for a Mere $2.9 Million in Bitcoin

Bitcoin, the digital currency at the center of some trade volatility after the Chinese government issued its clamp down order on the cryptocurrency, is surviving nicely, as prices rose above the $4,100-mark on Thursday. Believers in the virtual currency say that, in spite of several indications that government regulations are going to be part of its future, there are plenty of opportunities to use bitcoin now to purchase tangible assets.

Case in point – if you happen to have $2.9 million in bitcoin lying around in your virtual wallet, you could use it to buy a luxury, 5,000-square-foot, seven bedroom, 4.5-bath house situated next door to Robert Redford’s home in gorgeous Sundance, Utah, according to the Salt Lake Tribune (http://nnw.fm/niB72). Kevin Adell, a media mogel who runs a religious broadcasting network headquartered in Michigan, placed his Sundance property on the market the conventional way but didn’t get any takers. So, now, he’s offering to take bitcoin – and a lot of them.

Based on Thursday’s market valuation, one bitcoin is worth $4,189.42, which translates into approximately 693 bitcoin for the mansion. Adell, whose home is advertised as a “river house” on bitcoin-realestate.com (http://nnw.fm/W0pz9), says a title company has been lined up to convert the digital currency into cash.

“We’ll look for a buyer who has accumulated bitcoins when they were worth $1,” Adell is quoted in the article. “Now that they’re worth $4,000, they can convert them into a tangible asset. This opens a market for those people.”

Bitcoin investors who don’t have quite that much can still find plenty of companies accepting bitcoin as payment for goods. Among the more well-known companies accepting the cryptocurrency are Microsoft, Reddit, Virgin Galactic, OkCupid, Expedia, Newegg.com, Steam (an online desktop gaming platform), the Libertarian Party, and Overstock.com. There are also plenty of smaller companies dipping their marketing toes into the cryptocurrency world by advertising their willingness to accept bitcoin (http://nnw.fm/V6rwo).

Fidelity Investments, one of the world’s largest investment firms with $2.3 trillion in managed assets, said Thursday that the company has made several venture investments in bitcoin-related businesses. Fidelity’s chief executive, Abigail Johnson, said the firm is also looking at applications of blockchain technologies as it works with several leading universities (http://nnw.fm/mY7iD). Johnson, who is said to be a huge proponent of the digital currency, spoke publicly about Fidelity’s ventures into cryptocurrency earlier this year at Consensus, a bitcoin-themed conference in New York.

Bitcoin’s status as a top news maker will continue as regulation legalizing bitcoin exchanges comes online on October 1 in Japan. Following China’s recent ban on bitcoin exchanges, Japan has become the world’s largest bitcoin exchange market. Part-time Sundance resident Adell will be one of many people closely watching what happens as numerous nations around the globe begin to consider regulating bitcoin and other digital currencies.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, September 28, 2017

Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) and Canopy Growth (TSX: WEED) (OTC: TWMJF) Sign Definitive Licensing Agreement


  • Canopy Growth would license and exclusively sell certain Skinvisible Pharmaceutical topical products in Canada while having first rights to market those products in all countries except China and the U.S.
  • Skinvisible to develop Invisicare® technology hemp-based products to be sold under license by Canopy Hemp Corporation in Canada
  • Skinvisible’s Invisicare® technology cannabis-based topical products in the future, if and when THC- and CBD-infused products are legalized in Canada, are also in the agreement

Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) and Canopy Growth Corporation (TSX: WEED) (OTC: TWMJF) have announced a definitive agreement for Canopy to license and have exclusive marketing rights to Skinvisible’s topical treatments in Canada (http://nnw.fm/oKV1Y). Canopy shall have the first right of refusal to do the same for all other countries, except for China and the United States.

The agreement concerns Skinvisible’s two distinct product lines made of Invisicare® technology. Skinvisible will create unique topical hemp-based products to be launched by Canopy Hemp Corporation in Canada. Further, it would call for potential cannabis-based topical products, using Invisicare® technology when and if regulations allow the sale of CBD- or THC-infused topical products in Canada.

Skinvisible Pharmaceuticals is a R&D company that licenses its proprietary formulations made with Invisicare® in topically-applied products. Those products are designed to hold active ingredients on the skin for extended time periods, allowing for controlled release of actives. Invisicare® is a technology with 14 international patents and is able to offer improved delivery of ingredients (CBD or THC). The company notes that demand for topically-delivered cannabis is growing.

Canopy Growth is a diversified cannabis company that offers curated cannabis in dried, oil, and capsule forms. The company, which has numerous greenhouses and other production facilities, has already entered numerous partnerships with leading firms for sales in Canada and abroad. Canopy Growth has interests and operations on four continents globally and sells cannabis products, conducts R&D and educates healthcare practitioners.

“This agreement will have an immediate impact on our hemp product lines as this proven technology can be applied to a hemp oil product in today’s regulatory environment,” said Mark Zekulin, president of Canopy Growth.

President Terry Howlett of Skinvisible added, “This agreement with Canopy Growth Corporation is a significant milestone for Skinvisible. Canopy Growth is the leader and innovator in the cannabis space with over half a million feet of GMP-certified cannabis cultivation, a robust hemp operation, multiple commercialized brands in Canada, and rapid international expansion and partnerships underway including Germany, Australia, Brazil, Chile, Denmark and Spain.”

For more information, visit the company’s website at www.CanopyGrowth.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

ChineseInvestors.com, Inc. (CIIX) Again Names Paul Dickman as CFO, Pursues Exploding $7.2 Billion Legal Cannabis Market


  • CIIX is pursuing the $7.2 billion legal cannabis market with hemp-based cannabidiol (CBD) products; CIIX showed a 76% year-over-year operating revenues gain in FY2017
  • Dickman previously served as CFO from 2010-2016; Warren Wang, CIIX’s CEO, said Dickman will “build an infrastructure that supports long-term growth”
  • CIIX has plans to launch a hemp-based line of skin care products in China by year-end 2017 and is already marketing a line of hemp-infused cannabidiol products, “OptHemp,” through its U.S. subsidiary

ChineseInvestors.com, Inc. (OTCQB: CIIX) announced in an 8K SEC filing (http://nnw.fm/UA4wB) that Paul Dickman has returned as its chief financial officer, effective September 25, 2017. He served earlier as CFO of the company from July 2010 through October 2016. In his new position, he remains on the company’s board of directors and, as CFO, will now also be responsible for leading CIIX’s financial operations as well as instituting the company’s financial plan and strategies.

CIIX is aggressively pursuing the $7.2 billion legal cannabis market (http://nnw.fm/S17sa) with hemp-based cannabidiol (CBD) products targeted at the global Chinese-speaking community. By the end of 2017, it plans to market a hemp-infused skin care line in China through its CBD Biotechnology Co., Ltd. subsidiary. It is already marketing its OptHemp line of hemp oil-based products through its U.S. subsidiary, ChineseHempOil.com, Inc.

CIIX’s goal is to become the primary Chinese publicly traded company offering real-time financial information on its website. It conducts research & development on cannabidiol, as well as providing global retail distribution to the Chinese-speaking community. It has an online store based in the free trade zone of Shanghai, China, and plans to open a brick-and-mortar unit in San Gabriel, California. It markets hemp-based, legalized cannabidiol and other health products as well as planning the debut of a subscription website which will have the latest news on cryptocurrencies, such as bitcoin.

CIIX’s year-over-year operating revenues grew by 76% in FY2017. The consumer market for hemp-derived cannabidiol products is projected to grow at a 55% compound annual growth rate (CAGR) from $170 million in 2016 to $1 billion within three years (http://nnw.fm/oApL5). Consilium Global Research projects that CIIX sales will reach $14.8 million by FY2020, skyrocketing at a CAGR of nearly 100% (http://nnw.fm/73IRz). It also projects that the global CBD industry will reach $2.1 billion in consumer sales by 2020, propelled by a CAGR of about 80%.

“We are incredibly fortunate that Paul has agreed to return as our Chief Financial Officer,” Warren Wang, founder and CEO of CIIX, stated in a news release. “We look forward to his contributions in the financial and contractual management of the Company’s growth. Moreover, Paul shares our passion for excellence, innovation and entrepreneurial thinking. I am confident that Paul will serve effectively as our CFO just as he did in the past, helping us to build an infrastructure that supports long-term growth.”

For more information, visit the company’s website at www.ChineseInvestors.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Global Payout, Inc. (GOHE) CEO Discusses Innovative FINTECH Company’s Past, Present and Future


  • Innovative Global Reserve Platform enables seamless international payments
  • “Banking in a box” Global Reserve Platform provides full front-to-back office processing for banks
  • Solutions serve the global logistics industry, high-risk sectors and more

In a recent interview (http://nnw.fm/no3tA) with NetworkNewsWire, Global Payout, Inc. (OTC: GOHE) CEO James Hancock detailed where the innovative payment solutions company has been, where it is now, and where it plans to be in the future.

Global Payout is a frontrunner in the FINTECH revolution (http://nnw.fm/3HvjQ), offering versatile and innovative solutions for domestic and international organizations distributing money on a global scale. The company’s solutions include a cutting-edge “banking in a box” fintech payment system designed for online and mobile applications. This Global Reserve Platform solution enables account holders to maximize a full array of financial services while reducing operational costs.

This FINTECH system was built on the foundation of Global Payout’s original online payment platform, the Consolidated Payment Gateway (CPG). Introduced in 2014, the CPG made it possible for enterprise clients to transfer money to international bank accounts, mobile accounts and prepaid card accounts.

Global Payout’s origins date back to 2009, when it was founded as a prepaid card company, as Hancock explains in the interview. As Global Payout began dealing with international companies, it was realized that international connections were needed to properly serve them. Global Payout was obliged to go outside of the United States to acquire international issuing banks, as well as Visa and MasterCard.

Company leaders realized that while prepaid cards were good, what the world needed was a platform that enabled the movement of money to bank accounts in particular countries. Businesses were in need of an immediate and more responsive means of paying certain employees than was afforded by prepaid cards.

Rising to the occasion, Global Payout began developing the CPG to meet business-to-business needs rather than business-to-consumer. The platform enabled businesses to quickly, efficiently and cost-effectively make payments to employees and other individuals who lived outside the United States. Subsequent enhancements to the CPG have resulted in Global Payout’s Global Reserve Platform, which has integrated bank networks worldwide and, thereby, simplified the process of transferring money between businesses on an international scale.

This web-based platform:

Has provisions for blockchain technology within virtual currency markets, including bitcoin
Adopts 26 foreign languages at present
Performs currency exchange on a global level
Offers KYC compliance for all account holders and merchants
As Global Payout continues to grow, its efforts to identify the most profitable business segments have also increased. Current primary targets for the company include:

Logistics and shipping
International travel companies
Banks
Small to medium-sized businesses
The cryptocurrency and marijuana industries
A lack of fast and cost-effective payment options for companies in these industries opens the way for Global Payout to experience great success. The response from logistics leaders, for instance, has been exceptional. The efficacy of the Global Reserve Platform as a solution for supply chain companies is illustrated by a licensing agreement Global Payout recently signed with Cagney Global Logistics. Global Payout is also in negotiations with commercial banks, cannabis enterprises and entities in the cryptocurrency market.

For more information, visit the company’s website at www.GlobalPayout.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Boasts Oil Sands Technology that Could Make Tailings Ponds Passé


  • Versatile extraction process applicable to both water-wet and oil-wet sands
  • Green technology will save wildlife
  • Closed loop technology uses less water than traditional open loop processes

Tailings ponds, despite an innocuous name that makes them sound like an amusement park feature, are anything but amusing. They are as potentially treacherous as serpents hidden in the grass and remain so only because news reporting on their alarming threat has been scant. Containing mammoth quantities of residual toxic sludge, tailings ponds scar the landscapes already disturbed by the oil-sands industry. As if to highlight their destruction, many in Alberta, the hub of Canada’s industry, are decorated with bizarre orange anthropomorphic figures. These scarecrows are a feeble attempt to keep birds away. Many do not and perish slowly, ensnared by the paralyzing paste. Nevertheless, the peril to the environment posed by tailings ponds may soon abate. Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) has developed a unique, environmentally-safe, continuous flow, closed loop technology – a first in North America and probably in the world – that is likely to make tailings ponds for oil sands a relic of the past.

A tailings pond is a wet storage area for the unwanted residual material or ‘tailings’ left behind after mining and extracting resources, such as bitumen from oil sands. Tailings ponds allow the tailings to be continuously submerged, although some tailings can be ‘dry covered’ under soil. They are usually engineered structures but, in some instances, natural bodies of water have been turned into such dumps, which altogether ‘now cover 176 square kilometres and hold enough liquid to fill the equivalent of 390,000 Olympic-sized swimming pools’, according to the Toronto Star (http://nnw.fm/V8a9D).  CBC News has reported on a Canadian government federal study of 2014 that found ‘Alberta’s oil sands are polluting ground water and seeping into the Athabasca River’ (http://nnw.fm/T5ZAw). The extraction process developed by Petroteq could put an end to all that, since the technology is closed loop.

Petroteq Energy is focused on the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits, and, so, its oil-sands extraction technology does not require tailings ponds. The only elements that ever leave the closed-loop system are the extracted crude oil and the cleaned sands, which can be placed back in the earth or sold as clean sand for construction or fracking purposes.

This extraction technology is the result of almost five years of research by Petroteq’s research and engineering teams, headed up by the company’s chief technology officer, Dr. Vladimir Podlipskiy, well known for his work with benign solvents. During this time, Petroteq has gradually enhanced and improved the efficiencies of its technology at each stage of fabrication with better dryer/mixer components and a higher consistency of oil sands flow. The extraction technology is versatile; it can be effectively applied to both “water-wet” deposits, such as the oil sands in Alberta, Canada, or “oil-wet” deposits, such as the resources typically found in Utah.

It also solves the water problem. Processing oil sands requires large volumes of water, ‘about 3 barrels of fresh water to produce one barrel of oil’, according to Oil Sands Magazine (http://nnw.fm/2vYpB). This poses a particular challenge to western U.S. states like Utah, which are relatively arid. Petroteq’s extraction technology utilizes no water in the extraction process. It also produces no greenhouse gases and requires no high temperatures or pressures. In addition, the technology extracts up to 99 percent of all hydrocarbon content and recycles almost all the benign solvents. This certainly looks like technology that could protect the environment and the droves of geese, ducks, swans, and other species that cannot tell the difference between a tailings pond and a sparkling spring.

For more information, please visit www.Petroteq.energy

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Cannabis Companies Demonstrate the Diverse Nature of the Global Marijuana Market

NetworkNewsWire Editorial Coverage: The cannabidiol market is large and diverse; just a few years ago, it was rather small but by 2015, consumer sales had reached $202 million, according to the CBD Report published by The Hemp Business Journal. Cannabidiol sales are expected to grow to over $2 billion by 2020. The dollar amounts and projections may seem impressive, but they don’t tell the full story, as market demand is being fueled by an increasing number of applications. Medicinal marijuana is used to treat pain and inflammation, nausea, anxiety and diseases such as epilepsy and glaucoma. The medical community has also explored its cardiovascular health benefits and potential to reduce the incidence of diabetes, help people with Alzheimer’s disease and treat cancer. ChineseInvestors.com, Inc. (CIIX) (CIIX Profile) has added cannabis-based skincare products to the mix, as well as a Yelp-style app where products can be reviewed and discussed. It’s joined in the space by companies such as CV Sciences, Inc. (CVSI), Medical Marijuana, Inc. (MJNA), Terra Tech Corp. (TRTC) and MassRoots, Inc. (MSRT).

ChineseInvestors.com, Inc. (CIIX) is staking its position in the market with several product lines, including hemp-infused skin care products. Cannabis is known to have anti-inflammatory and antioxidant properties. The company noted the benefits in this area in an August 2017 press release (http://nnw.fm/z9WPp). They include improvements to skin complexion, thanks to the omega-3 and omega-6 fatty acids present in hemp seed oil. The fatty acids help keep skin moist and stimulate collagen production, helping skin to become firmer. In fact, the human endocannabinoid system includes cannabinoid receptors in the skin.

A recent press release (http://nnw.fm/Tb3Bi) highlights the scope of the company’s hemp-infused product line. CIIX’s wholly owned enterprise, CBD Biotechnology Co. Ltd., has completed the record filing process with the China FDA for the CBD Magic Hemp Series, a line of skin moisturizer, primer and peptide collagen solutions. These cannabidiol-infused products employ the antioxidant and anti-inflammatory benefits of CBD. The ability to sell these products is good news for investors.

Alan Klitenic, Director of Investor Relations for CIIX, was recently featured in an interview with SmallCapVoice.com (http://nnw.fm/flQB8) to discuss CIIX’s hemp-infused skin care line, as well as other company achievements.

“…We have manufactured this product: CBD Infused skin care products line with a design patent. This is a real milestone for us at ChineseInvestors.com. We are going to spend money and promote our CBD Hemp Oil and CBD infused skin care products in China going forward from now and thru 2018.” He also noted that the company is ready to start building distribution channels and begin retail sales, online commerce, social media, and direct marketing initiatives to maximize revenue and the value for shareholders.

Fully aware of the demand for medical cannabis, CIIX has worked to improve the user experience as well. It has developed an investing process, known as the ChineseInvestors Method, and introduced various web-based tools to disseminate market information to investors. That puts investors on the front lines of China’s $30 billion per year skin care product industry.

The company also developed and launched a Chinese-language social media app, approved for download via the Apple App Store. It enables users to view, discuss, and write reviews on cannabis strains and marijuana dispensaries. People can use the application’s maps to find retailers, view business summary reports and see product recommendations. Social media isn’t CIIX’s only strategy, as a recent partnership with the digital agency Launch Haus LLC has spawned a marketing campaign aimed at expanding CIIX’s direct-to-consumer e-commerce business. It also appointed Keevin Gillespie as acting president of ChineseHelpOil.com, Inc., a wholly-owned subsidiary of CIIX, to brand and promote the OptHemp health product line.

As active as the company has been in the cannabis space, it is not the only mover in a fast-growing and diversifying market.

Another company with a diverse product line is CV Sciences (CVSI). Its pipeline consists of CVSI-007, a smokeless tobacco cessation product. The drug candidate comes in the form of a chewing gum, which contains nicotine and synthetic CBD. Consumer products already on the market include PlusCBD Oil, a dietary supplement sold in capsules, sprays, balms, drops, concentrates and vape liquid in nearly 1,000 retail locations. Vape blends are sold via CVSI’s Purified Liquids store, while cannabinoids are sold wholesale to serve the growing CBD wellness market. The company recently presented at the Natural Products Expo East 2017, in Baltimore, Maryland, and the MJAC2017 InvestorsHub International Cannabis Conference in Los Angeles, California.

The international cannabis market is also experiencing considerable growth, and Medical Marijuana (MJNA) distinguishes itself as the first publicly traded cannabis company in the U.S. and the first to introduce legal medical cannabis in Brazil. Its e-commerce store sells numerous brands and categories of CBD oil, including capsules, isolates, chewing gum, vape oil, vaporizer pens and body lotions and creams. In addition to pen-type vaporizers, the company also sells portable and tabletop units, as well as an electric dabbing system for vaporizing medical concentrates. All products are sold as dietary supplements rather than medical marijuana, so they can be purchased legally without doctor recommendations.

Terra Tech (TRTC) supplies the medical cannabis market via brands such as IVXX™, a cultivator and producer of different concentrates and other products, and Edible Garden®, which uses Dutch hydroponic farming methods to produce Global Food Safety Initiative-certified products, including a wide range of herbs and leafy greens. The company therefore serves the food industry as well, but it also specializes in high-grade medical cannabis that is produced at its Blüm™ facility. In addition, Terra Tech’s MediFarm division manages the permit application and procurement process for marijuana cultivators, while GrowOp Technology designs and manufactures horticultural equipment and automation/control software.

MassRoots (MSRT) offers an extremely diverse product line via its online catalog. Searchable by plant type, flavors, effects, health conditions, and manufacturer, it gives customers one of the most simple and comprehensive sources of edibles, lotions, drops and more. The company’s website has an educational article section plus a news page with frequent updates. Another resource featured on the site is a local dispensary search function, but the company also serves other businesses, providing a connection with point-of-sale systems that enable retailers to display their inventory in real time and provide customers with simple online ordering.

Cannabis companies are serving a fast-growing and diversifying market by various means. The skincare and healthcare products and social app from ChineseInvestors.com, Inc. (CIIX) are prime examples. The products and services of the companies discussed above have become relevant in the current business climate and show potential to keep pace with broader industry growth.

For more on ChineseInvestors.com please visit: ChineseInvestors.com, Inc. (CIIX)

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Cannabinoid Biosynthesis Poised as Potential Game-Changer in Drug Development

NetworkNewsWire Editorial Coverage: As the marijuana market continues its widespread growth, researchers remain merely at the threshold of exploring the manifold potential medical applications of cannabis. At present, more than 90 individual cannabinoid compounds have been discovered within the cannabis plant—each one potentially possessing crucial disease-fighting properties either on its own or combined with other compounds. Historically, however, it has been incredibly difficult to extract most of these compounds from the marijuana plant in adequate quantities and purities to be tested pharmaceutically. Overcoming this stumbling block in medical cannabis advancement, Vancouver-based biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) (IMLFF Profile) has developed a pioneering, high-yield biosynthesis process that enables the manufacture of all 90+ naturally occurring cannabinoids. This groundbreaking development could have an enormous impact in forwarding the efforts of other companies within the cannabis sector, including GW Pharmaceuticals (NASDAQ: GWPH), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), Axim Biotechnologies, Inc. (OTCQB: AXIM) and 22nd Century Group, Inc. (NYSE: XXII).

InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) novel approach to cannabinoid biosynthesis represents a potentially game-changing breakthrough in drug development. Many efforts by other companies to develop synthetic cannabis derivatives have failed. In comparison with other microbial platforms, InMed’s E. coli system has proven, through substantial experimentation, to be heartier and more efficient for the manufacturing of cannabinoids.

The process of naturally sourcing most cannabinoid compounds from the cannabis plant is extremely time-consuming, involving the tasks of planting, growing, harvesting and extracting. It is also very costly; can be low-yielding because of crop fluctuations; and involves various hard-to-remove impurities like pesticides, herbicides and fertilizers. Additionally, this process yields only two to three cannabinoids that can reach adequate quantities to justify the process; the remaining cannabinoid compounds are only yielded in trace amounts and are not accessible through natural sources.

While many have tried to chemically synthesize these compounds for pharmaceutical use, the chief problem with such an approach is it is usually very hard to derive cannabis compounds that are identical to the ones that occur naturally. Slight variations in structure can change both the effectiveness and safety of these compounds. The difficulty, tedium, costliness and time-consuming nature of the process is, overall, off-putting and creates a great deal of chemical waste.

The proprietary cannabinoid manufacturing process pioneered by InMed addresses this problem through biosynthesis, which is the process of utilizing naturally occurring cannabinoid DNA to produce cannabinoid compounds in a laboratory setting. The advantages of this process are multifold, resulting in:

Compounds that are identical to naturally occurring cannabinoids
Pure, individual cannabinoids that can be manufactured without the necessity of separating the many compounds from one another
A time- and cost-effective process
High quality control throughout the process thanks to production in a laboratory setting
The capability for all 90+ cannabinoids to be manufactured for the same reasonable cost
InMed is thus able to tap into the enormous medical potential of every cannabinoid, in particular the minor ones, due to this ability to access them in an economically sound way. The financial and time-consuming nature of other biosynthesis methods continue to pose stumbling blocks for other pharmaceutical companies.

Recently, InMed announced the filing of a provisional patent application—the first of many—relating to this proprietary biosynthesis program for manufacturing cannabinoids (http://nnw.fm/Z30dH). Once converted into an international Patent Cooperation Treaty (PCT) application and pursued in key jurisdictions on a global scale, this first patent application will give InMed significant commercial protection for its biosynthesis program, which is an E. coli-based expression system. This series of patent applications will particularly focus on the superiority of E. coli-based expression systems in comparison to other approaches; maximizing production of cannabinoids and related compounds through gene optimization; and additional proprietary developments and data related to InMed’s breakthrough biosynthesis program. Over time, InMed intends to actively convert this first patent filing, along with subsequent provisional patents, into national-stage filings in every major commercial jurisdiction.

InMed’s revolutionary cannabinoid biosynthesis program is one of three core assets for the company. The other two are a bioinformatics assessment tool that targets specific cannabinoids in treating key diseases and a drug development program that includes INM-750 for Epidermolysis bullosa and INM-085 for glaucoma.

InMed is assembling a strong management team to bring its biosynthesis program to commercialization. This team includes Ben Paterson, P.E., whose consulting services were recently retained by InMed (http://nnw.fm/vx1Bo). Paterson previously served as a senior engineering advisor for Eli Lilly and Company, spending 24 years in that company’s biosynthesis division. His extensive expertise will help InMed transition from pilot-scale to commercial-scale manufacturing.

The company’s management team also includes president and CEO Eric A. Adams, who is a veteran biopharmaceutical executive with extensive experience in company and capital formation, global market development, mergers and acquisitions, and licensing and corporate governance; Chief Scientific Officer Dr. Sazzad Hossain, Ph.D., M.Sc., who has more than two decades of academic and industrial experience in new drug discovery and natural health product development; Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM, who is a proven leader in developing cannabinoid therapies; Alexandra D.J. Mancini, M.Sc., who serves as the senior vice president of clinical and regulatory affairs and possesses more than 30 years of global biopharmaceutical R&D experience, with emphasis in clinical development and regulatory affairs; and CFO Jeff Charpentier, who is a biopharmaceutical industry veteran with more than 25 years of experience.

InMed’s breakthrough approach to cannabinoid biosynthesis has enormous potential in helping other companies in their cannabis-related drug development efforts—companies like GW Pharmaceuticals (GWPH), the company behind the world’s first prescription drug derived from the cannabis plant, Sativex®, which is approved for the treatment of spasticity due to multiple sclerosis. GWPH’s lead cannabinoid product candidate is Epidiolex®, a liquid formulation of pure plant-derived cannabidiol being developed for the treatment of a number of rare childhood-onset epilepsy disorders. Other companies include Zynerba Pharmaceuticals (ZYNE), whose product candidates are “synthetically manufactured per FDA/CGMP regulations” in an effort to “provide consistent potency and eliminate impurities in the product”; Axim Biotechnologies (AXIM), which is developing a clinical pipeline of cannabinoid-based products such as its MedChewRx™ chewing gum for the treatment of irritable bowel syndrome; and 22nd Century Group (XXII), a plant biotechnology company focused on genetic engineering and plant breeding which allows the increase or decrease of the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants. The availability of all 90+ cannabinoid compounds enabled by InMed’s process could mean the difference between success and failure in the development of drugs to treat various key diseases.

“This novel approach to the biosynthesis of cannabinoids is a game-changer for drug development,” said Dr. Vikramaditya Yadav, assistant professor of Chemical and Biological Engineering at the University of British Columbia and a co-inventor of InMed’s biosynthesis technology (http://nnw.fm/Z30dH). “The importance of producing cannabinoids that are identical to the naturally occurring compounds cannot be overstated. Many drug development efforts with synthetic derivatives have failed.”

With roadways opening up in cannabinoid research and this pioneering new access to every cannabinoid compound rather than just a few of them, the potential is virtually limitless as companies like those named pursue drug development activities within the medical cannabis field. There is no telling what breakthrough cures and treatments may emerge as a result, but it is indeed an exciting time in the burgeoning cannabis space.

For more information on InMed Pharmaceuticals, please visit: InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF)

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Wednesday, September 27, 2017

EVIO, Inc. (SGBYD) Changes Name, Adopts New Ticker Symbol and Announces a Reverse Stock Split


  • Name change to EVIO, Inc., from Signal Bay, Inc., reflects fact that EVIO Labs division generates majority of company volume
  • New ticker symbol of EVIO will become effective October 3, 2017, for the legalized cannabis industry’s quality control testing and ancillary advisory services company
  • Reverse stock split is positioned to attract institutional investors to provide funding for company’s vision of becoming a leading biotechnology firm in the cannabis industry

EVIO, Inc. (OTCQB: SGBYD) has changed its name from Signal Bay, Inc. and also announced a reverse stock split (http://nnw.fm/ViB3C). The life science company will also have a new ticker symbol, EVIO, effective October 3, 2017, pending approval. EVIO Labs provide the cannabis industry with accredited analytical testing and scientific research.

EVIO engineered the 1:100 reverse stock split in order to reduce its outstanding shares from three billion to one billion. After the split, the par value of each share of common stock remains unchanged.

“We are excited about the future direction of the Company, under the new name of EVIO, Inc.,” William Waldrop, EVIO CEO, stated in a news release. “We aligned the corporate name with our EVIO Labs Division which accounts for a majority of our revenue and lays a foundation for becoming a leading cannabis biotechnology company. Furthermore, with the effectiveness of the reverse stock split, we structured the company to be best positioned for institutional investors to provide the necessary funding to complete our vision. These are exciting times to be part of the fastest growing industry in the world, and EVIO is now positioned to take full advantage of this opportunity.”

Additionally, the company has licensed its brand and cannabis technology in Colorado to Phytatech CO, LLC. Phytatech will now operate under the EVIO Labs brand (http://nnw.fm/9uRLq).

For more information, visit the company’s website at www.EVIOLabs.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Targets Specific Diseases with its Proprietary Biotechnologies


  • Provisional patent application protects unique process yielding pharmaceutical grade, bio-identical cannabinoids
  • Proprietary research allows production of synthetic cannabinoids for therapeutic use with certain diseases
  • Early stage clinical trials are expected to begin in 2018 for a drug targeting a rare children’s skin disorder

Imagine having a painful disease that causes your skin to blister at the slightest minor injury. Even just scratching an itch or accidentally rubbing against a rough object could cause peeling blisters and acute suffering. Epidermolysis bullosa, a genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States, currently has no approved treatments, according to the Dystrophic Epidermolysis Bullosa Research Association of America. Researchers at InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), however, hope to treat this unmet medical need with a topical drug called INM-750 that includes multiple biosynthesized cannabinoids as its active ingredients.

Vancouver, Canada-based InMed Pharmaceuticals is a preclinical biotech company that specializes in developing novel drug therapies by manufacturing cannabinoids with the potential to have a therapeutic effect on specific diseases. The company’s biosynthesis platform works by inserting the plant’s DNA into E. coli bacteria that has the internal ability to manufacture specific cannabinoid compounds.

Couple this approach with a proprietary bioinformatics data assessment tool created by InMed Pharmaceuticals, and the possibilities are endless. In its corporate presentation, the company details the potential benefits of biosynthesis of cannabinoids as wide-ranging, noting that the procedure could enable enhanced quality control and purification while unlocking the minor cannabinoids that are currently too difficult and expensive to produce and study (http://nnw.fm/d7MHp).

Glaucoma, one of the world’s leading causes of blindness, is another life-changing disease that InMed’s proprietary research is zeroing in on. InMed’s INM-085 biosynthesized, topical glaucoma treatment will be the first of its kind – utilizing numerous cannabinoids for optimal efficacy as it treats the affected eye’s cells and optic nerve tissues. The company projects the potential revenue for these two drugs alone at $6 billion a year (http://nnw.fm/L32rz).

But there are other, equally devastating diseases that InMed Pharmaceutical researchers propose targeting in their quest to biosynthesize therapeutic drugs from cannabis and other botanical sources. Rheumatoid arthritis, epilepsy, asthma and diabetes are some of the more well-known names. The benefits of using InMed’s proprietary biosynthesis procedure to manufacture any of the 90-plus identified cannabinoids in marijuana reads like a wish list for investors:


  • There are significant cost savings versus the traditional method of growing thousands of plants and then extracting cannabinoids
  • Quality control, which includes enhanced production and purification, means a superior, standardized product
  • InMed’s comprehensive database uses a bioinformatics platform to select specific cannabinoid combinations that may help treat targeted diseases
  • Preclinical formulation of therapy drugs this year will lead to expected clinical trials in 2018

Leading research estimates set the 2016 legal cannabis market in North America anywhere from $6.7 billion to $7.2 billion. Growth projections are also “off the charts,” as a stunning compound annual sales growth rate of 25 percent is expected through 2021, and a $50 billion global market is considered possible by 2025 (http://nnw.fm/l0EKZ).

Looking ahead, InMed Pharmaceuticals President and CEO Eric A. Adams said he believes the company’s technology will have a huge impact on the booming cannabis industry.

“When I saw the technology that InMed has, I knew right away that it was going to be something big,” Adams said in a recent interview published in MERRY JANE, an online resource for news, culture and video covering cannabis. “The science behind the company is a real game changer (http://nnw.fm/O3ptU).”

In a move to strengthen the company’s core, InMed has also retained the consulting services of Ben Paterson, P.E., who will assist in defining the pathway for the scale-up, purification and manufacturing strategies for the company’s cannabinoid biosynthesis program. Patterson is a principal consultant at PatersonChemE Consulting, LLC.

Paterson has nearly four decades of experience in developing pharmaceutical manufacturing and purification processes. He previously spent 37 years with Eli Lilly and Company as a senior engineering advisor, including 24 years in the biosynthesis division. His expertise includes first defining processes in the lab, then scaling up to pilot and commercial scale.

“Mr. Paterson brings significant experience in all facets of biosynthesis manufacturing and facility design,” Adams said in a news release announcing Paterson’s appointment (http://nnw.fm/0jdLo). “His expertise directing complex capital projects, overseeing facilities and equipment, and interfacing with various stakeholders will be a significant asset to InMed.”

For more information, visit the company’s website at www.InMedPharma.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

AppSwarm, Inc. (SWRM) Continues to Support the Games People Play as a Business Accelerator


  • At least 150 million Americans play games
  • Business accelerator for mobile app developers
  • Footprint in the mammoth video games market

With the latest Entertainment Software Association (ESA) report revealing that half of America plays video games, the excitement surrounding AppSwarm, Inc.’s (OTC: SWRM) foray into the industry appears to be based on very robust rationales. AppSwarm is a business accelerator focused on acquiring software applications for all forms of devices. The company actively pursues partnerships with software development companies that exhibit historical profitability and growth capability. Leveraging its resources in capital, management, marketing and product development, AppSwarm is able to add value to the collaboration. Now with a portfolio of entertainment software apps, AppSwarm is showing it’s ahead of the game in what continues to be a highly lucrative industry.

When psychiatrist Eric Berne wrote in 1964 about the “Games People Play,” giving an account of his study into the psychology of human relationships, it was apparent that he must have glimpsed into the extent to which games provide comfort and a sense of identity. Largely addressed to adults, Berne’s work was a reminder of how naturally we take to games; nothing is as easy as child’s play. These inclinations do not fall away quickly. The average age of the video game player is not some teenage number, but 35, and more women 18 years and over play video games than boys under the age of 18, according to the ESA 2017 report (http://nnw.fm/iM4E5).

Again, contrary to public perception, only about one-quarter of gamers are under 18; most gamers are adults. In all, ‘more than 150 million Americans play video games, and 65 percent of American households are home to at least one person who plays video games regularly, or at least three hours per week,’ As will be expected, the economic consequences of the games people play are considerable. ‘In 2016, the industry sold over 24.5 billion games and generated more than $30.4 billion in revenue. Total game sales included purchases of digital content such as online subscriptions, downloadable content, mobile applications, and social networking games.’ Overall, ‘computer and video game companies provided jobs to more than 220,000 people in 50 states.’

With such a huge demand for games, developers are hard pressed to get their creations to market and often rely on accelerators like AppSwarm. Sometimes confused with business incubators, business accelerators are an entirely different animal. While incubators focus on getting ideas off the ground, an accelerator helps a business that’s already running run better. As this piece in Inc. explains (http://nnw.fm/T2bYA), ‘while incubators help companies stand and walk, accelerators teach companies to run.’ AppSwarm targets businesses that have not only a promising future, but also a good past.

AppSwarm employs a proprietary screening process, called the Swarm, to select the companies with which it would like to work. These collaborations can take one of several forms:  stock purchase agreements, royalty agreements, joint ventures, partnerships or acquisitions. The company offers complete, end-to-end services for mobile application development across all major platforms, including Apple iPhone, RIM’s BlackBerry, Google’s Android, and Microsoft’s Windows Mobile, and it has agreements in place with all of the major application stores. AppSwarm will act as a partner to increase marketing visibility, in addition to providing the range of resources that small firms, young entrepreneurs and application developers need to commercialize their applications effectively.

So far, AppSwarm has been winning its game. It’s current game portfolio includes Turtles, Huh?, which was ranked as the top iOS family games app in five countries, ranked in the top five iOS family games apps in 22 countries and ranked in the top 10 iOS family games apps in 44 countries.

For more information, visit the company’s website www.App-Swarm.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Grey Cloak Tech Inc. (GRCK) Signs Letter of Intent to Acquire Eqova Life Sciences


  • Clinical-grade full spectrum hemp oil products created for licensed medical practitioners included
  • Science-backed education, superior products meet requirements of medical profession
  • Medical cannabinoid product revenue projected to reach $1.15 billion by 2020

Grey Cloak Tech Inc. (OTC: GRCK) recently announced that it has signed a binding Letter of Intent to purchase Eqova Life Sciences, a Colorado-based medically-focused company producing clinical-grade full spectrum hemp oil products. To date, no other hemp oil company has exclusively focused on the medical practitioner market, leaving this important segment largely underserved. Grey Cloak Tech, which is known for its click fraud prevention products, has been searching for a way to enter the growing cannabinoid industry, as it noted in a news release (http://nnw.fm/IE4So).

According to The Hemp Business Journal, sales of products derived from cannabinoids more than tripled from 2014 to 2017, rising to $358 million. Additional revenue predictions for the medical marijuana industry point to $1.8 billion in sales by 2022, the report states. Grey Cloak Tech expects to dominate the medical practitioner market with science-backed education and superior products that utilize standardized dosing and unique delivery methods. Market professionals rightly require a safe, consistent product that meet strict conditions.

Eqova CEO Patrick Stiles, who is responsible for founding and growing several nutraceutical brands, has sold millions of dollars in products online through a variety of channels. Eqova’s medical advisory board seeks the most effective phytocannabinoid-rich hemp oil, ingredients and delivery methods – combining them into innovative, cutting edge products that deliver standardized dosing and consistent pharmaceutical grade ingredients that actually help patients. All Eqova products go through rigorous third-party testing before and after manufacturing, ensuring that Equova’s products contain no or only trace amounts of psychoactive ingredients such as THC (tetrahydrocannabinol).

“Today, consumers are smarter than ever before. They demand superior products but also want it backed up with education,” Stiles said in a news release. “The days of empty promises are over. This is why we exclusively partner with medical professionals to bring our full spectrum hemp oil products to their patients.”

William Bossung, CFO of Grey Cloak Tech, said the acquisition is contingent on meeting various obligations and conditions and will be consummated as soon as is reasonably practicable.

“The possibility of growing substantial revenues certainly exists with Equova,” Bossung said. “With Mr. Stiles’ business savvy, we expect to have substantial increases in revenue.”

For more information on Grey Cloak Tech Inc., visit www.GreyCloakTech.com

For information about Eqova Life Sciences, visit www.Eqova.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Safeguard Scientifics (NYSE: SFE) to Present at ‘Disruptive Growth and Healthcare Conference’ in New York


  • One-day conference will be held at the Grand Hyatt in New York City
  • Safeguard Scientifics will webcast its 4 p.m. ET presentation
  • SVP and CFO Jeffrey B. McGroarty will present

Safeguard Scientifics, Inc. (NYSE: SFE) will be presenting at the Disruptive Growth and Healthcare Conference (http://nnw.fm/TH0Rs) in New York on September 27.

Safeguard Scientifics offers capital and expertise to help grow technology-driven businesses in the healthcare, digital media and financial services fields. The company’s SVP and CFO, Jeffrey B. McGroarty, will be presenting at the conference at 4 p.m. ET at the Grand Hyatt in New York, and it will also be webcast. The conference will encompass 30-minute presentations as well as one-on-one meetings with scheduled investors.

Typically, Safeguard deploys between $5-25 million over the course of its partnership with a company. It initially invests in a Series A or B Round and opportunistically in a Seed Round.

For more information on SFE, visit the company’s website at www.Safeguard.com

For more information about the Conference, refer to Disruptive Growth and Healthcare Conference (http://nnw.fm/TH0Rs) and www.DisruptNYC.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Overstock.com, Inc. (NASDAQ: OSTK) to Present at ‘Disruptive Growth and Healthcare Conference’ in New York


  • One-day conference will be held at the Grand Hyatt in New York City
  • Online retailer Overstock.com, Inc. will present to investors
  • Worldstock.com, a store within Overstock, has added an augmented reality (AR) feature, offering consumers true-to-life models in 3D and high resolution

Overstock.com, Inc. (NASDAQ: OSTK) will be presenting at the Disruptive Growth and Healthcare Conference (http://nnw.fm/TH0Rs) in New York on September 27.

Overstock.com, Inc. is an online retailer selling a broad range of products for the home, including furniture, decor, rugs, bedding and home improvement items. The Salt Lake City, Utah-based company also sells apparel, jewelry, electronics and specialty items, offering consumers access to hundreds of thousands of products from third-party sellers.

Worldstock.com is a store within Overstock that sells artisan-crafted products from global sources. Most recently, the company added augmented reality (AR) within its iOS shopping app. Company shoppers using the AR app on their cell phones and tablets with iOS11 can see true-to-life-size models in 3D of products in high resolution.

For more information on OSTK, visit the company’s website at www.Overstock.com

For more information about the conference, refer to Disruptive Growth and Healthcare Conference (http://nnw.fm/TH0Rs) and www.DisruptNYC.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Lithium, Fuelling the New Millennium

NetworkNewsWire Editorial Coverage: Lithium stocks are on fire. Ignited by demand for lithium-ion batteries for mobile phones, laptops and electric vehicles, lithium stocks have soared since the beginning of last year. Surging demand and inadequate market supply are driving up price and intensifying the search for more lithium by major producers and junior miners like 92 Resources Corp. (TSX.V: NTY) (FSE: R9G2) (OTCQB: RGDCF) (92 Resources Profile).  This growth is further evidenced by how the three largest lithium producers have performed since January 2016: FMC Corp. (FMC) is up over 160%; Albemarle Corp. (ALB) is up over 180%; and Sociedad Quimica y Minera de Chile (SQM) surged a scorching 260%-plus. Despite these gains, the market for lithium batteries still has untapped upside potential, but the decision by Tesla, Inc. (TSLA) to build a $5 billion Li-ion Gigafactory to meet its requirement of lithium-ion battery packs sharpens the focus on the shortage of lithium and the tight supply of Li-ion energy storage technology.

There’s a worldwide scramble to find more lithium. Sales of lithium salts are estimated at $1 billion annually, but with burgeoning global demand, both sales and price could spike even more dramatically. In fact, in 2015, the price for 99% pure lithium carbonate imported to China spiked to more than $13,000 per ton, more than double the prior year’s price.

92 Resources Corp. (TSX.V: NTY) (FSE: R9G2) (OTCQB: RGDCF) is focused on capitalizing on the global lithium shortage. The junior mining company is positioning to be at the vanguard of the renewable energy market and holds several lithium mining properties that are showing positive results from all initial indicators.  The company began work at its Hidden Lake Lithium Project site this summer with a grant awarded under the Northwest Territories Mining Incentive Program. A maiden drill program for the project, now underway, has shown exceptional results. The project was undertaken to determine if industry standard lithium extraction techniques applied to typical spodumene (lithium aluminum silicate) concentrates could also be applied to concentrates produced from the pegmatites at Hidden Lake. The company reported that scoping test work was highly successful with an overall extraction of 97% achieved (http://nnw.fm/Cuqn9).

“The Project has now been significantly de-risked through the high quality, low-iron spodumene confirmed to be present at Hidden Lake, as well as the high lithium extractions that may be expected using standard methods,” 92 Resources president and CEO Adrian Lamoureux stated in the press release.

Hard rock lithium, the same type derived from the spodumene-bearing lithium pegmatites at Hidden Lake, accounts for about one-third of global reserves.

92 Resources also recently acquired three more highly prospective hard-rock lithium properties located in the James Bay region of Quebec, Canada (http://nnw.fm/c98zB). The Corvette, Eastmain, and Lac du Beryl properties consist of a combined 115 mineral claims totalling over 14,000 acres, complementing the company’s existing portfolio of assets. Each project was the subject of due-diligence site visits prior to acquisition, which included the examination and sampling of known pegmatite occurrences. Pegmatites are also known as extreme igneous rocks because they contain exceptionally large crystals and minerals, such as lithium, that are rarely found in other types of rocks. A small area of each property was evaluated during the site visits, and, most importantly, pegmatite outcroppings were confirmed present on each property.

Furthermore, a significant spodumene (lithium aluminum silicate) bearing pegmatite was discovered and sampled at Corvette, with spodumene crystals up to one meter in length, within an outcrop measuring approximately 150 meters by 30 meters.

“As we continue to aggressively advance our flagship Hidden Lake Lithium Project, we feel it is critical to maintain a pipeline of additional high-quality, early-staged, lithium pegmatite projects, each with potential as stand-alone opportunities. We are very excited by these new additions to the company’s already high-quality portfolio of assets,” Lamoureux stated in a press release.

92 Resources is clearly fast on the trail of the next great lithium deposits and expects to announce more developments in the near future.

Lithium has a myriad of essential uses and is crucial in rechargeable batteries for mobile phones, laptops, digital cameras and electric vehicles. The increasing demand for rechargeable devices and electric vehicles has created a dependence on lithium sparking a global search for new lithium fields. The success of Tesla Inc. (TSLA), a first mover in electric vehicles, is a harbinger of the entire automotive industry. At full-capacity, Tesla’s new Li-ion Gigafactory is expected to have an annual output of 35 gigawatt-hours, equivalent to the entire world’s battery production capacity. The demand for Li-ion batteries will explode as the grid begins to modernize to handle a massive influx of mainstream electric vehicles. The lithium dependent electric-vehicle (EV) market could reach 30 percent market penetration in the next dozen years, according to the International Energy Agency. Morgan Stanley analysts forecast the production and use of electric cars to rise to 81% of new auto sales by 2050.

At its current pace, demand for lithium is growing at 10 percent annually. However, it’s easily conceivable that demand could soar even more as new technological uses come into play. In 2015, Goldman Sachs stated that “lithium is the new gasoline.”  It’s increasingly obvious that we’re in the midst of an energy transformation where lithium battery technologies will have the potential to dramatically impact nearly every aspect of life. Immense opportunities are already unfolding with the adaption of electric vehicles and stationary energy storage systems. To profit from this new energy transformation, investors should have direct or indirect exposure to lithium and/or lithium batteries.

The largest lithium producer in the world, Albemarle Corp. (ALB), has long been a global leader in the specialty chemical business. Albemarle’s lithium business segment mines lithium and converts it into different forms along the value chain, like lithium carbonate and lithium hydroxide, or value-added specialties like butyl lithium and lithium aluminum hydride. With its acquisition of Rockwood Holdings in 2015, the company now controls one of the only operating lithium brines in North America and operates another lithium brine located in Chile. Albemarle also holds a 49% share in the spodumene mine of Talison Lithium in Australia and is expanding production in 2019 under a joint venture. Albemarle has locked up long-term supply agreements with their customers, but this advantage will erode over time as customers on expiring contracts leave to buy from the lowest cost producers. Given that the stock is trading at an elevated multiple due to its lithium growth profile, any shock to growth expectations will lead to a rapid repricing.

Headquartered in Chile, Sociedad Quimica y Minera S.A. (SQM) is among the largest producers of lithium in the world, producing over 45,000 tons of lithium carbonate equivalent per year. SQM says it plans to expand its lithium carbonate capacity in Chile to 63,000 metric tons by 2018. In addition to lithium, the company produces specialty plant nutrients, iodine derivatives, potassium chloride, potassium sulfate and industrial chemicals. With the sky-rocketing demand for lithium batteries in 2017, shares of SQM surged from 2014 trading lows to knock on all-time highs and are now above $58 a share. The company inconsistently pays a moderate dividend yielding around 3% and carries a hefty PE ratio over 45.

FMC Corp. (FMC) through its lithium division, owns and operates a 17,000+ tons per year lithium brine facility in Argentina, where political upheaval has sparked discord, riots and rampant inflation. FMC is a large and diversified multinational chemical company servicing global agricultural, consumer and industrial markets, and lithium represents only a small portion of company revenues. The company operates in three business segments: FMC Agricultural Solutions, FMC Health and Nutrition and FMC Lithium. Over $90, the company’s shares are trading at an all-time high with a PE ratio over 58. The company does pay a quarterly dividend of 17 cents per share, which yields less than three-quarters of one percent on an annual basis. As with most established lithium producers, shares of FMC have trended much higher since 2016. Looking to boost lithium revenues, FMC says it plans to increase lithium hydroxide capacity to 30,000 metric tons per year by the end of 2019 after increasing to 18,000 metric tons this year.

None of these chemical conglomerates are pure play lithium-focused companies, which does offer investors some reduced investment risk since overall company performance is tied to other chemicals and metals. However, each of these lithium behemoths are trading at or near all-time highs and don’t provide the direct exposure or maximum upside to the lithium market that a junior mining company could offer.

Leaders in international metals and minerals research, industry consultants at Roskill have estimated that in just eight years over 785,000 metric tons per year of lithium carbonate equivalent will be needed to meet global demand (http://nnw.fm/riS7f). That equates to a 26,000-metric-ton shortfall from expected supply in 2025. Compared to 217,000 tons of demand and 227,000 tons of supply this year, many other analysts expect even greater demand, even larger lithium deficits and further price increases for this new millennium fuel. Given driving demand, supply deficits, technological advancements and expansive need, investors in lithium could be more than amply rewarded.

For more information on 92 Resources Corp. visit 92 Resources Corp. (TSX.V: NTY) (FSE: R9G2) (OTCQB: RGDCF)

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Tuesday, September 26, 2017

LottoGopher Holdings Inc. (OTCQB: LTTGF) (CSE: LOTO) (FRA: 2LG) Board Member Kevin Harrington Talks to Benzinga about the Company’s Growth Strategy


  • LTTGF board member Kevin Harrington, original star of hit series ‘Shark Tank’ and infomercial pioneer, talked to Benzinga about growing LTTGF into 20+ additional states, using celebrity endorsements and implementing a “360 degree” strategy to raise profile and attract new customers
  • U.S. lottery industry is estimated to be between $70 billion and $80 billion nationally, with California, initial state for LTTGF operations, a $6.3 billion lottery market
  • LTTGF has named celebrity William Shatner, actor and Star Trek star, as its spokesperson; Shatner represented The Priceline Group (NASDAQ: PCLN) for 14 years, helping to build its stock from an IPO of $16 per share to $1,862 today with a market cap of $91.3 billion

LottoGopher Holdings Inc. (OTCQB: LTTGF) (CSE: LOTO) (FRA: 2LG) board member Kevin Harrington, former ‘Shark Tank’ star and a pioneer of the infomercial industry, told investors on Benzinga (http://nnw.fm/rL9Ic) that they should keep an eye open to attractive entry points to the stock. “I’m an optimistic investor and I like to get involved at the right time,” he said.

LTTGF currently operates in the $6.3 billion California market (http://nnw.fm/O03Nf) as a lottery messenger service that permits users to buy state lottery tickets online via credit and debit cards, manage their accounts and receive the latest lottery news. The company has identified 22 more states which it plans to enter. Eventually, it hopes to expand into the national U.S. lottery market (http://nnw.fm/iY0dV).

“We are operating a service to help people get tickets,” Harrington told Benzinga. “I call it the ‘Uber Eats’ of lotteries. We do a similar thing: You want a lottery ticket, you go online and order it, we go and handle it getting printed for you and put it in your account…It’s like an on-demand courier service.”

He added that the company’s focus is raising its profile and acquiring more customers. “Our vision is to become the leading lottery messenger service in the United States,” said James Morel, founder and CEO of the company.

“We’ll be taking a 360 degrees approach to getting customers at a number that is less than the lifetime value of a customer, so that we can get a profit in the process,” Harrington said. “LottoGopher will be using TV, radio, digital media, celebrity endorsements…all the resources that are available…Each particular medium will focus on a particular demographic.”

LTTGF is offering players in California state lotteries such as MEGA Millions, SuperLotto Plus and POWERBALL. Participants can avoid waiting and buy tickets online after registering and paying a subscription fee. There are no other commissions or hidden fees. Bitcoin and ethereum are also accepted.

Harrington said that LTTGF will be seeking to enter more states and acquire additional customers. “This plays right into my background, which is finding customers. This is what we are working on right now.  We have dozens of things happening as we speak, and over the next 60 days, that are pretty groundbreaking.”

LTTGF also recently named William Shatner as its spokesperson (http://nnw.fm/9Dk5N). Shatner is best known for his role in Star Trek, but he has also appeared in Boston Legal and T.J. Hooker, as well as numerous stage productions and movies. Shatner, in 1997, was named spokesperson for Priceline (NASDAQ: PCLN). That stock skyrocketed from an IPO price of $16 per share to its current PPS of $1,862. Today, the company has a market cap of $91.3 billion.

For more information, visit the company’s website at www.LottoGopher.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com